Laporan Indikator Puskesmas Oktober 2019
Diunggah oleh
Yuni NovitaLaporan Indikator Puskesmas Oktober 2019
Diunggah oleh
Yuni NovitaCommon questions
Didukung oleh AIIndicators include low antibiotic prescription rates for ISPA non-pneumonia (24%) and considered antibiotic usage for diarrheal cases (28%). Additionally, the use of generics at 100% suggests adherence to cost-effective prescribing practices aligned with broader clinical guidelines .
The prudent antibiotic prescription habits at Puskesmas Rikit Gaib, with a 24% rate for ISPA and 28% for diarrhea , play a crucial role in mitigating antibiotic resistance. These practices suggest that the facility prioritizes reducing unnecessary antibiotic exposure, thereby contributing to prolonged antibiotic efficacy and public health sustainability .
The data indicates that Puskesmas Rikit Gaib manages prescriptions by utilizing generics universally, focusing on symptomatic treatments such as Zink and PCT across conditions . Acute conditions like ISPA are managed with a moderate use of antibiotics, while chronic conditions apparent from long-term prescriptions (e.g., for myalgia) emphasize cost-effective and symptom relief practices .
For ISPA non-pneumonia, the average number of medication items per patient was 3.7727, whereas for diarrhea non-specific, it was 2.8, and for myalgia, it was 3.0 . This variation indicates a higher variety of medications used for ISPA cases, possibly due to the complexity or diversity of symptoms in respiratory ailments compared to the others .
The uniform use of generics (100%) at Puskesmas Rikit Gaib , coupled with effective prescription practices, can reduce healthcare costs and increase medication access for lower-income populations. This strategy potentially enhances public health outcomes by ensuring affordability without compromising treatment quality, though it requires ongoing quality assurance in generic production .
In October 2019, antibiotics were prescribed in 28% of non-specific diarrhea cases at Puskesmas Rikit Gaib . Given the general guideline to limit antibiotic use in non-bacterial diarrheal cases to mitigate antibiotic resistance, this percentage could suggest a moderate adherence to appropriate prescribing practices. However, inspection of specific cases and symptoms would be necessary to fully evaluate appropriateness .
Antibiotic use in myalgia cases does not appear to be a standard practice, likely due to the non-infectious nature of myalgia. The Puskesmas Rikit Gaib report indicates regular medications without antibiotics for myalgia, reflecting adherence to guidelines that emphasize non-antibiotic treatments unless a specific bacterial infection is diagnosed .
In October 2019 at Puskesmas Rikit Gaib, a notable pattern in ISPA non-pneumonia prescriptions was the relatively low usage of antibiotics, with only 24% of prescriptions including them, despite 100% of medications being generic . This suggests a cautious approach to antibiotic prescribing, aligning with guidelines to reduce antibiotic resistance .
The percentage of injection medications for myalgia treatment at Puskesmas Rikit Gaib was 38% . This reflects reliance on injectable forms possibly for faster pain relief or when patients cannot take oral medications. It highlights a practice aligned with immediate symptomatic relief in acute settings, though over-reliance should be monitored .
The high usage of generic medications at 100% implies a focus on cost-effectiveness and accessibility in healthcare. This strategy potentially lowers healthcare costs for both the facility and patients, increases drug availability, and complies with governmental and WHO recommendations for using generics to enhance medical access in underserved areas .